Tirzepatide is a dual GIP/GLP-1 agonist with a slightly different molecular structure
A research-grade BPC-157 COA should show an HPLC chromatogram with a purity percentage of 99% or higher, mass spectrometry confirming identity matching the GEPPPGKPADDAGLV sequence (molecular weight 1419 Da), a batch or lot number, testing date, and analytical laboratory name
The question of whether these compounds should be used indefinitely parallels the conversation about blood pressure medications and statins
Our company was established in the year 2010
They respond professionally to quality concerns
A provider should reassess progress, side effects, hormone markers, metabolic health, and whether the peptide should be continued, adjusted, paused, or stopped